For citation:
. . FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2012;5(2):3-8. (In Russ.)
Views: 107
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Fullscreen
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Author
Keywords
COPD
NAFLD
NASH
Pharmacoeconomics
QALY
budget impact analysis
children
clinical and economic analysis
cost-effectiveness analysis
cost-utility analysis
drug supply
health technology assessment
multiple myeloma
non-alcoholic fatty liver disease
pharmacoeconomic analysis
pharmacoeconomic modeling
pharmacoeconomic studies
pharmacoeconomics
pharmacoepidemiology
rare diseases
systematic review
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
